BioGrad Secures $25 Million to Fuel Innovations in Science & Healthcare Education

We are thrilled to announce that BioGrad has successfully raised $25 million in a recent funding round, marking a significant milestone in our transformative journey since our establishment in 2014 by Dr. Natalie Kenny, Matthew Fagan, and Jay Fitzgerald. Based in the vibrant Liverpool City Region, BioGrad has comprehensively developed over the past nine years, expanding our capabilities through our specialized divisions: BioGrad Education, BioGrad Biobank, BioGrad Prenatal, and BioGrad Diagnostics. This substantial funding will enable us to accelerate our commitment to advancing science and healthcare education, as well as enhancing our pioneering efforts in regenerative medicine and clinical research. With this investment, we aim to expand our biobanking services and develop cutting-edge diagnostics that can transform patient care. The support we have garnered not only underscores the confidence investors have in our vision but also provides a solid foundation for our future innovations. As we look ahead, our goal is to empower the next generation of scientists and healthcare professionals while driving breakthroughs that can positively impact countless lives. We remain steadfast in our mission to bridge the gaps in healthcare by fostering an environment of excellence and innovation, and this funding is a key step in making that vision a reality. We would like to extend our heartfelt gratitude to our investors, partners, and the extended BioGrad community for their unwavering support as we embark on this exciting new chapter.